HIV patients should be included in early clinical trials of anti-TB drugs

29 septiembre 2015

Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide, yet the majority of these patients are excluded from the early stages in the development of new, anti-tuberculosis drugs, according to research.